Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000252800 (LOC124900352) encodes a small Cajal body-specific RNA (scaRNA), a type of non-coding RNA molecule. ScaRNAs are typically involved in the biogenesis and modification of small nuclear RNAs (snRNAs) within the Cajal bodies of the cell nucleus. However, there are no current reports indicating that this particular gene product functions as a drug target, nor is there sufficient evidence linking it directly to any disease mechanism or as a biomarker. Its locus is defined (chromosome 14: 63,945,990-63,946,131, GRCh37), but beyond annotation as a non-coding RNA, additional molecular or clinical relevance has not been established[7]. This entry does not represent a canonical receptor, enzyme, transporter, or other classical therapeutic target; rather, it falls under the category of non-coding RNAs with currently unknown or uncharacterized specific function in human biology. If a therapeutic or research relevance is later established, the information may need to be updated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Cajal body-specific RNA.